HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells by Huiying Zhang et al.
Zhang et al. Respiratory Research 2012, 13:69
http://respiratory-research.com/content/13/1/69RESEARCH Open AccessHSULF-1 inhibits ERK and AKT signaling and
decreases cell viability in vitro in human lung
epithelial cells
Huiying Zhang1,2, Donna R Newman1 and Philip L Sannes1*Abstract
Background: Heparan sulfate proteoglycans (HSPGs) modulate the binding and activation of signaling pathways of
specific growth factors, such as fibroblast growth factor-2 (FGF-2). Human endosulfatase 1 (HSULF-1) is an enzyme
that selectively removes 6-O sulfate groups from HS side chains and alter their level and pattern of sulfation and
thus biological activity. It is known that HSULF-1 is expressed at low levels in some cancer cell lines and its
enhanced expression can inhibit cancer cell growth or induce apoptosis, but the mechanism(s) involved has not
been identified.
Methods: HSULF-1 mRNA expression was assessed in five normal cells (primary human lung alveolar type 2 (hAT2)
cells, adult lung fibroblasts (16Lu), fetal lung fibroblasts (HFL), human bronchial epithelial cells (HBE), and primary
human lung fibroblasts (HLF)) and five lung cancer cell lines (A549, H292, H1975, H661, and H1703) using
quantitative real time polymerase chain reaction (qRT-PCR). H292 and hAT2 cells over-expressing HSULF-1 were
analyzed for cell viability, apoptosis, and ERK/Akt signaling, by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay, TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) assay,
and Western Blot, respectively. Apoptosis pathway activation was confirmed by PCR array in hAT2, H292, and A549
cells.
Results: HSULF-1 was expressed at a significantly lower level in epithelial cancer cell lines compared to normal
cells. Infection with recombinant adenovirus for HSULF-1 over-expression resulted in decreased cell viability in H292
cells, but not in normal hAT2 cells. HSULF-1 over-expression induced apoptosis in H292 cells, but not in hAT2 cells.
In addition, apoptosis pathways were activated in both H292 and A549 cells, but not in hAT2 cells. HSULF-1
over-expression reduced ERK and Akt signaling activation in H292 cells, which further demonstrated its inhibitory
effects on signaling related to proliferation.
Conclusions: These results indicate that HSULF-1 is expressed at lower levels in H292 lung cancer cells than in
normal human alveolar cells and that its over-expression reduced cell viability in H292 cells by inducing apoptotic
pathways, at least in part by inhibiting ERK/Akt signaling. We hypothesize that HSULF-1 plays important roles in
cancer cells and functions to modify cell signaling, inhibit cancer proliferation, and promote cancer cell death.
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Heparan sulfate (HS) proteoglycans are major compo-
nents of extracellular matrix (ECM) and cell surfaces.
They function as dynamic interfaces between cells and
their external environment. They help cells affix to and
maintain the extracellular scaffolding of the ECM as well
as directly internalize lipid factors. Their shed ecto-
domain fragments can even neutralize injurious agents
[1-4]. Importantly, they regulate essential cell signaling
pathways which influence proliferation, differentiation,
migration, and survival [3,5]. HS side chains are cova-
lently linked to core proteins to form proteoglycans,
such as syndecans or glypicans, which associate with or
integrate into the lipid bi-layers of cells. HS side chains
are also key structural features which facilitate ligand
binding and receptor activation for an important group
of signaling molecules which includes fibroblast growth
factors (FGFs), wingless signaling glycoproteins (Wnts),
Sonic hedgehog (Shh), hepatocytes growth factor (HGF),
vascular endothelial growth factor (VEGF), and a newly
defined tumor necrosis family member, a proliferation-
inducing ligand (APRIL) [6-11]. For example, the loss of
responsiveness to FGF by cells lacking endogenous
heparan sulfate can be restored by the addition of ex-
ogenous soluble heparin [12]. Importantly, there is
strong evidence that the nature of the sulfate bonds and
the pattern distribution of sulfation are critical factors
influencing signaling pathways [13,14]. FGF-2 signaling,
for instance, requires the N- and 2-O-sulfate groups of
heparan sulfate for binding to FGF-2 ligands and the
presence of 6-O-sulfate groups for the activation of FGF
receptor-1 (FGFR-1). Accordingly, 6-O-desulfated hep-
arin, which binds to FGF-2 ligands but fails to bind to
the FGFR, can decrease the FGF-2-induced proliferation
of CHO677 cells [15].
Human endosulfatase-1 (HSULF-1) is the enzyme that
specifically removes 6-O sulfate groups from HS side
chains, thus modifying the pattern of sulfation and po-
tentially changing its biological specificity. Although its
quail analog QSULF-1 was found to be a secreted pro-
tein, HSULF-1 has been shown to be both secreted and
localized on external cell surfaces as well as electrostati-
cally attached to cell membranes [13,16,17]. Recently,
the role HSULF-1 plays in cancer cell proliferation and
embryonic development has been studied by several
groups. The expression of HSULF-1 was found to be
down-regulated in ovarian, breast, and hepatocellular
cancers compared with normal epithelium [10,18], and
its over-expression reduced tumor growth in several
cancer types [19,20]. These collective observations sup-
port the notion that HSULF-1 plays an important role in
the biology of some cancer cells. However, few studies
have examined HSULF-1 activity in normal and cancer
cells of the lung, the regulation of its expression, and itscapacity to modulate lung cell proliferation and relevant
signaling via hydrolyzation of 6-O sulfate groups. Ac-
cordingly, the aim of this study was to examine the
expression of HSULF-1 and the effects of its over-
expression in transformed human epithelial cells of
pulmonary origin as compared with normal human al-
veolar type 2 cells.
Materials and methods
Cell preparation
H292, A549, HFL-1, and 16Lu cells were obtained from
the American Type Culture Collection (ATCC) (Mana-
ssas, VA) and cultured in RPMI1640 (Roswell Park
Memorial Institute 1640), F12K, and EMEM (Eagle’s
minimal essential medium) media, respectively, with
10% FBS and antibiotics. Human AT2 cells and HLF
cells were isolated from organ donor lungs obtained by
the University of North Carolina Cystic Fibrosis/
Pulmonary Research and Treatment Center Tissue Pro-
curement and Cell Culture Core (Chapel Hill, NC). Iso-
lated hAT2 cells were maintained in low-glucose DMEM
(Dulbecco’s modified Eagle medium) medium sup-
plemented with 10% FBS and Antibiotic-Antimycotic
solution containing penicillin, streptomycin, and ampho-
tericin B (Mediatech, Manassas, VA). Isolated HLF cells
were maintained in high-glucose DMEM medium with
10% FBS and antibiotics. H1975, H661, and H1703 cells
were purchased from Duke University’s Cell Culture Fa-
cility (Durham, NC) and maintained in RPMI medium
with 10% FBS and antibiotics. HBE cells were gifts from
Dr. Kenneth Adler and was maintained in Ham’s F-12/
DMEM medium supplemented with 5 mg/ml insulin, 10
ng/ml epidermal growth factor, 0.1mM dexamethasone,
5 mg/ml transferring, 20 ng/ml cholera toxin, and anti-
biotics. The use of human cells was in compliance with
the Helsinki Declaration, and approved by the North
Carolina State University Institutional Review Board for
the Protection of Human Subjects in Research.
hAT2 and HLF cell isolation
Cells were isolated according to a scaled-up, modified
version of the original Dobbs [21] procedure. In brief, an
entire lobe from a donor cadaver lung was excised, can-
nulated, inflated to full capacity with Solution I, a PBS
(phosphate buffered saline)-based solution lacking cal-
cium and magnesium but containing EGTA, and lavaged
and drained multiple times to remove macrophages, air
and mucus. Divalent cations were restored by inflating
with Solution II, a PBS-based solution containing mag-
nesium and calcium. The lobe was inflated to capacity
with elastase (Worthington Biochemicals, Lakewood, NJ)
dissolved in Solution II (13 units/ml) and incubated at
37°C for up to forty minutes. Peripheral pieces were ex-
cised from the digested lobe and obvious bronchiolar
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then minced into cubic millimeter size, using triple scis-
sors, in Solution II containing DNase (Worthington).
The minced tissue was transferred to a flask on ice and
5 ml of FBS was added to each 100 ml of suspension to
neutralize the elastase. The suspension was shaken vig-
orously side-to-side in a 37°C water bath for 3 minutes
to mechanically release the hAT2 and HLF cells from
the tissue. The suspension was then filtered through a
single layer of moistened cheesecloth several times until
large pieces of undigested tissue were removed, then
through two layers of cheesecloth twice and three layers
once. The suspension was passed through 165 μm nylon
mesh and finally through 42 μm nylon mesh. The filtrate
was centrifuged at 1000 rpm (300 g) for 10 minutes at
4°C, and each cell pellet was re-suspended in 5 ml
DMEM (without FBS) and pooled. A 100 μl aliquot of
the cells was diluted 1:10 in a Trypan Blue solution
and counted using a hemacytometer. Cells were re-
suspended in sufficient DMEM so that around 20 mil-
lion viable cells could be seeded on each of 40 Petri
dishes coated with human IgG (Sigma, St. Louis, MO).
Dishes of cells were incubated at 37°C for 1 hour to
allow macrophages and white blood cells, as well as
many fibroblasts, to adhere. Non-attached hAT2 cells
were recovered by gently rocking each dish several times,
transferred to 50 ml tubes, and centrifuged. Each hAT2
cell pellet was re-suspended in 5 ml DMEM and all cells
were pooled in a single 50 ml tube. To further reduce
fibroblast contamination, a mouse monoclonal anti-
CD90/anti-fibroblast antibody, clone AS02 (EMD Bios-
ciences, Inc., La Jolla, CA), was added to the cells for a
10 minute incubation at 4°C with gentle inversion. Ex-
cess antibody was removed by increasing the volume to
50 ml with DMEM/0.1% BSA and by pelleting the cells.
The re-suspended cells (in 20 ml DMEM/0.1% BSA)
were then incubated with pan-mouse-IgG Dynabeads for
30 minutes at 4°C with gentle inversion. The cell sus-
pension was brought to 45 ml with DMEM/0.1% BSA
and divided into three 15 ml tubes. Tubes were placed
into a magnetic holder and the Dynabead-labeled fibro-
blasts were immobilized along the tube sides. The non-
selected hAT2 cells were pooled in a 50 ml tube, counted,
and plated in DMEM/10% FBS on rat-tail collagen-coated
tissue culture dishes. After a medium change the next
day, cells were cultured for 48 hours before further treat-
ment. To obtain HLF cells, a portion of the mixed cell
population which was not ASO2 depleted was placed on
tissue culture dishes and cultured in complete medium
until fibroblasts began to proliferate. These HLF cells
were lightly trypsinized, transferred to flasks for amplifi-
cation, and cryopreserved at passage 3. Cell culture and
treatment, H292, A549, H1975, H661, H1703, HFL-1,
16Lu, HBE, HLF, and hAT2 cells were cultured for48 hours and harvested for RNA analysis to measure the
basal expression of HSULF-1. H292 and hAT2 cells were
then cultured to 50% confluence and transduced with
HSULF-1 adenovirus at 2, 5, 10, 20, 50, and 100 multi-
plicities of infection (MOI). After 24 or 48 hours, en-
zymatic conversion of formazan, an indirect measure of
cell proliferation/viability, was measured by MTT assay.
TUNEL assay was also utilized to confirm the cell death
in transduced H292 cells over-expressing HSULF-1. In
addition, H292, A549, and hAT2 cells, transduced at 10
MOI to over-express HSULF-1, were harvested for RNA
and apoptosis pathway activation was analyzed by PCR
array. Finally, selected signaling events influenced by
over-expression of HSULF-1 were analyzed in H292 cells
with or without 25 μg/ml heparin (Bovine lung, sodium
salt, EMD Biosciences).Preparation of HSULF-1 adenovirus
Over-expression of HSULF-1 in epithelial cells was ac-
complished by adenoviral delivery of the human SULF-1
gene driven by a CMV promoter. An Ultimate ORF (open
reading frame) clone (IOH38422) in the pENTR221 vector
(Invitrogen, Carlsbad, CA) was used to introduce the
protein coding sequence of HSULF-1 into the pAd/
CMV/V5-DEST vector (Invitrogen) by an LR Clonase II
transfer and ligation reaction. The recombinant plasmid
was transformed into TOP10 E. coli hosts and successful
transformants were selected on Ampicillin plates. The
HSULF-1 coding DNA was completely sequenced by pri-
mer walking to confirm 100% fidelity and a perfect clone
was amplified and used to transfect 293A cells to pro-
duce adenovirus. Amplified adenoviruses were then
titered by the Hexon antibody/DAB method and used to
infect experimental hAT2 and H292 cells for transient
over-expression of HSULF-1.MTT assay
A measure of cell proliferation/viability was obtained
by a colorimetric assay which utilized the capacity of
live cells to change 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) from yellow to a
purple precipitate which could be dissolved in DMSO.
Twenty-four, 48, or 72 hours after adenovirus infection
of H292 and hAT2 cells, culture medium was discarded
and the MTT solution (Sigma) was added to a final con-
centration of 1 mg/ml. After 3 hours of incubation at
37°C, the solution was removed and the formazan pre-
cipitate was dissolved in DMSO. Optical densities
(OD) were measured at 570 nm using a microplate ELISA
reader. Data was expressed as a percentage of untreated
control cells and analyzed by ANOVA followed by Stu-
dent’s t-test.
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Apoptosis was determined by TUNEL (Terminal deoxy-
nucleotidyl transferase dUTP nick and end labeling)
assay which detects the DNA fragmentation produced in
apoptotic cells. Cells over-expressing HSULF-1 or lacZ
(controls) were cultured for 72 hours, trypsinized, cul-
ture, washed, and re-suspended in 500 μl PBS. Each cell
suspension was delivered into 5 ml of 1% paraformalde-
hyde. After incubation on ice for 15 minutes, cells were
pelleted and supernatant discarded; cells were then
washed twice in 5 ml of PBS and finally re-suspended in
500 μl PBS. This cell suspension was added to 5 ml of
ice cold 70% ethanol, incubated on ice for 30 minutes,
and pelleted again. Apoptosis was analyzed by a TUNEL
kit (Invitrogen) which uses an anti-BrdU mouse antibody
and Alexa Fluor 488 conjugate. Cells undergoing apop-
tosis exhibited a bright green nuclear fluorescence at ex-
citation/emission wavelengths of 495/519 nm. Total cell
nuclei were stained with DAPI (blue) and detected at ex-
citation/emission wavelengths of 358/461 nm. Photo-
micrographs were taken of random fields with a Meiji
MT6300H fluorescence microscope at 20X magnifica-
tion with an Infinity 3 camera; DAPI and BrdU pictures
were merged using Image J. A minimum of 3 fields was
randomly selected and total cells were counted in each
field to achieve a minimum number of 150 total. Apop-
totic ratios as apoptotic cells/total cells are expressed as
Mean ± standard error (SD) from different fields.
Reverse transcription and quantitative real-time PCR
Cells were cultured as above for 48 hours and total RNA
was isolated using the RNeasy Plus Mini Kit (Qiagen,
Valencia, CA) according to manufacturer’s protocol.
Four micrograms of RNA of each sample were reverse-
transcribed utilizing the High-Capacity Archive Kit (Ap-
plied Biosystems, Foster City, CA). cDNAs were diluted
to a final concentration of 10 ng/ml and 10 μl of each
diluted sample (equivalent to 100 ng of RNA) were
PCR-amplified in triplicate using Taqman primers and
probes (Hs00392839_m1) (Applied Biosystems) on an
iCycler (Bio-Rad, Hercules, CA). Data analysis was per-
formed using the delta-delta CT method to compare the
relative expression of HSULF-1 normalized to GAPDH
in different cell types; values and standard errors were
graphed in Excel.
PCR array analysis of apoptosis signaling pathways
hAT2, A549, and H292 cells were infected with lacZ
or HSULF-1 adenovirus at 10 MOI for 48 hours. Cells
were harvested and total RNA was isolated and puri-
fied by RNeasy Plus Mini Kit (Qiagen). Concentrations
were measured spectrophotometrically at 260 nm and
1 μg of total mRNA was used as template for cDNA
synthesis utilizing the High Capacity Archive Kit (AppliedBiosystems). Produced cDNA was added to SybrGreen
PCR master mix (SABiosciences, Frederick, MD) and ali-
quotted into each well of the ready-to-use PCR array
PAHS-012 (Human apoptosis array, SABiosciences). Real-
time PCR cycling was performed according to the protocol
and data were analyzed using on-line programs from
SABiosciences. The 84 apoptosis-related genes analyzed
included tumor necrosis factor (TNF) ligand and receptor
family, B-cell lymphoma 2 (BCL2) families, Caspases,
Inhibitors of apoptosis (IAP), caspase recruitment domain
family, death domain, death effector domain, and p53 fam-
ily members.
Preparation of cell lysates
Cells, cultured in 100 mm dishes, were rinsed with PBS.
RIPA buffer (150 μl), containing PhosStop and Complete
EDTA-free Protease inhibitors (Roche, Indianapolis, IN),
was added to dishes. Cells were scraped and collected in
microcentrifuge tubes and sonicated three times. Sam-
ples were then shaken on ice for at least 30 minutes and
centrifuged at 14,000 rpm for 30 minutes at 4°C. Super-
natants were transferred to fresh microcentrifuge tubes
and total proteins in each sample were quantitated by
Pierce 660 nm Protein Assay Kit (Pierce Biotechnology,
Rockford, IL). The lysates were stored at -80°C.
Western analysis
Equal amounts of proteins were subjected to electro-
phoretic separation in MOPS running buffer at 200V for
60 minutes on NuPage 4-12% Bis-Tris gels using the
Novex X-Cell II system (Invitrogen). Proteins were
transferred to nitrocellulose membranes and blocked
with TBST/5% milk for 1 hour. Blocked membranes
were incubated in Tris Buffered Saline containing 0.1%
Tween20 and 5% BSA (TBS/T/BSA) with primary anti-
bodies to HSULF-1 (Abcam, Cambridge, MA), p-ERK,
ERK, p-Akt, Akt, and GAPDH (Cell Signaling Technol-
ogy, Danvers, MA) overnight at 4°C with agitation. After
washing in TBS/T, blots were incubated in TBS/T with
5% milk (TBS/T/milk) containing secondary antibodies
conjugated to horseradish peroxidase (Cell Signaling
Technology) for 2 hours with agitation. Bands on the
membrane were detected by chemiluminescence using
SuperSignal West Pico or Dura substrate (Pierce) and
visualized by autoradiography. Integrated optical dens-
ities measured by ImageJ were exported to Microsoft
Excel for analysis.
Statistical analysis
Certain RT-PCR data were log transformed to obtain
normally distributed variables. Values were expressed as
mean ± SD and statistical significances were established
by one or two tailed t-test and ANCOVA (analysis of
covariance). A level of p<0.05 was considered significant.
Zhang et al. Respiratory Research 2012, 13:69 Page 5 of 15
http://respiratory-research.com/content/13/1/69Results
HSULF-1 basal expression is lower in lung cancer cells
than in normal lung cells
To evaluate the expression of HSULF-1 in cells of pul-
monary origin, five normal lung cells (fibroblasts (16Lu),
fetal lung fibroblasts (HFL), primary lung fibroblasts
(HLF), primary alveolar type 2 (hAT2) cells, and bron-
chial epithelial cells (HBE)) and five lung epithelial can-
cer cell lines (A549, H292, H1975, H661, and H1703)
were cultured and mRNAs were analyzed. HSULF-1 was
expressed at a significantly higher level in normal lung
cells (hAT2 (61-fold), HFL-1 (94-fold), 16Lu (133- fold),
HBE (74-fold), and HLF (362-fold) compared to cancer
cells (A549 as control, H292 (6-fold), H1975 (10-fold),
H661 (2-fold), and H1703 (12-fold)) (Figure 1). This sug-
gests that the expression of HSULF-1 may be constitu-
tively lower in lung cancer cells compared to normal cell
lines or primary cells.
Over-expression of HSULF-1 decreased cell density in
H292 cancer cells but not in human primary hAT2 cells
H292 and hAT2 cells were infected with adenovirus at
various MOIs for lacZ or HSULF-1 over-expression.
Forty eight and 72 hours post-infection, quantitative
real-time PCR and Western blot were performed to
analyze the expression of HSULF-1 mRNA and protein,
respectively. Results showed that the levels of HSULF-1
mRNA and protein were significantly increased (Figure 2,
A – C). Seventy-two hours post-infection, phase-contrast
microscopy showed that hAT2 cells infected with lacZ
adenovirus at 100 MOI (Figure 3A) were morphologically
similar to untreated cells (data not shown), and were typ-
ically squamous in appearance with a centrally located




























Figure 1 Relative levels of baseline HSULF-1 expression. Five normal c
(A549, H292, H1975, H1703, and H661) were cultured for 48 hours and the
normalized to HSULF-1 expression in A549 cells (lowest expression), log tra
from three separate analyses. All the cancer cells express HSulf-1 in a signif
determined by one tailed Student’s t-test.adenovirus, hAT2 cells showed little or no significant
change in morphology and density (Figure 3, B – G)
compared with those infected with lacZ adenovirus
alone. H292 cells infected with lacZ adenovirus were
small, polygonal cells with a centrally positioned nucleus
(Figure 3H) and morphologically similar to untreated
cells (data not shown). In contrast to hAT2 cells, the
morphology and cell density of H292 cells were altered
by HSULF-1 adenovirus in a MOI-dependent manner.
Low MOIs [2,5] did not significantly change the morph-
ology or the cell density (Figure 3, I – J), while 10 MOI
induced a visible decrease in cell density and an increase
in the number of floating cells (Figure 3K). Higher
HSULF-1 adenovirus MOIs (20, 50, and 100) not only
induced morphologic changes in H292 cells but also
decreased cell density (Figure 3, L – N).
To quantitatively assess the viability of HSULF-1 over-
expressing cells compared to lacZ over-expressing con-
trol cells, an MTT assay, which measures the activity of
mitochondrial enzymes that reduce MTT to formazan
and indirectly quantifies viable cells, was performed. In
primary human alveolar hAT2 cells transduced with
HSULF-1 adenovirus at 100 MOI, enzymatic activity was
reduced to 90%, 83%, and 83% at 24, 48, and 72 hours,
respectively, while hAT2 cells transduced with lacZ
adenovirus at 100 MOI showed activity reduced to
92%, 87%, and 84%, compared to uninfected controls
(Figure 4, A – C).
In H292 cells, 100 MOI of HSULF-1 adenovirus
reduced MTT activity to 85%, 52%, and 39% at 24, 48,
and 72 hours, respectively, while lacZ adenovirus re-
duced it to 95%, 88%, and 79% of uninfected controls,
respectively. HSULF-1 also significantly reduced MTT
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levels of HSULF-1 mRNA were analyzed by RT-PCR. Values were
nsformed to obtain normal distribution, and expressed as means ± SD





No adv lacZ 5 10 20 50 100






























*   *




lacZ, MOI - 100 - - -
HSULF-1, MOI - - 10 20 50 B
hAT2
GAPDH
lacZ, MOI - 100 - - - - - 100 -




Figure 2 Demonstration of HSULF-1 over-expression in hAT2 and H292 cells by quantitative real time PCR (qRT-PCR) and Western blot.
(A) Cells were infected with HSULF-1 adenovirus at MOIs from 5 to 100, with lacZ adenovirus at 100 MOI serving as a control. 48 hours
post-infection, qRT-PCR was performed to assess the expression level of HSULF-1 mRNA. Values are shown as mean± SD from 2 experiments.
* Significant differences at p<0.05, compared with untreated and lacZ controls, are determined by Student’s t-test. Western blot was utilized to
assess the expression level of HSULF-1 protein 72 hours post-infection in (B) hAT2 cells and (C) H292 cells.
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D – F). These results demonstrate that HSULF-1 over-
expression lowers formazan conversion activity and thus
indicates a reduction in viability in lung cancer cell lines,
but not in normal lung cells.
Over-expression of HSULF-1 induces apoptosis and
related pathways in lung epithelial cancer cells
To determine whether the reduced cell viability observed
in the MTT assay was caused by apoptosis or by toxicity,
lacZ or HSULF-1 over-expressing cells were subjected to
TUNEL assay 72 hours after infection to assess DNA
fragmentation as a quantitative measure of apoptosis.
Results, confirmed in representative photographed fields,
indicated that a high level of lacZ adenovirus (100 MOI)
did not induce apoptotic cell death in H292 cells, with
only rare co-localization of FITC-labeled foci (DNA frag-
ments) with blue (DAPI) stained nuclei (Figure 5A).
However, HSULF-1 over-expression did induce an
increased number of FITC-labeled foci indicative of
apoptosis in H292 cells, proportional to progressively in-
creasing MOIs (Figure 5, B – G). Ratios of FITC-labeled
foci to DAPI-labeled nuclei (total) indicated that HSULF-1
transduction, even at 5MOI, induced significant apoptosiscompared to lacZ control at 100 MOI, and higher MOIs
of HSULF-1 adenovirus resulted in significantly greater
apoptosis (Figure 5H).
PCR arrays were then used to determine whether
apoptotic signaling pathways were altered by HSULF-1
over-expression. Scatter plot analysis illustrated that data
points representing activation of these apoptosis-related
genes deviated less from those of lacZ adenovirus con-
trol in hAT2 cells (Figure 6A) than in H292 or A549
cells (Figures 6B and 6C) after over-expression of
HSULF-1. Genes that were up- or down-regulated more
than 2-fold (Table 1) revealed that in hAT2 cells, a total
of six genes (BCL2A1, BCL2L11, CASP7, DAPK1, IGF1R,
and TNFRSF9) were specifically activated by forced ex-
pression of HSULF-1. Of the four pro-apoptotic genes
(DAPK1, BCL2L11, CASP7, and TNFRSF9), only DAPK1
was down-regulated (-4.2-fold). The other three were
up-regulated, but fold changes for two of these were
close to 2. TNFRSF9 was up-regulated (4.5-fold). The
two anti-apoptotic genes (BCL2A1 and IGF1R) were both
down-regulated, but again close to the 2-fold change cut-
off. This suggested that, on balance, there was insuffi-
cient activation of relevant pro-apoptotic pathways to
support apoptosis compared to control cells.
Figure 3 (See legend on next page.)
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Figure 3 Representative photomicrographs of hAT2 and H292 cells after over-expression of HSULF-1. hAT2 (B – G) and H292 (I – N) cells
were infected with HSULF-1 adenovirus with MOIs at 2, 5, 10, 20, 50, and 100 (top to bottom in sequence), with lacZ adenovirus at 100 MOI
serving as control (A and H). Photomicrographs were taken after 72 hours under a phase contrast microscope at 200Х magnification.
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(BAX, CASP6, CASP8, CIDEA, DFFA, FAS, TNFRSF9,
and TNFSF10), four anti-apoptotic genes (BAG1, BAG4,
IGF1R, and BCL2A1), and five unrelated genes
(GADD45A, CD70, TNFSF8, MCL1, and TP73) were spe-
cifically altered by HSULF-1 expression. Of the eight pro-
apoptotic genes, three (CASP6, CASP8, and TNFSF10)
were down-regulated, but only CASP6 by a relatively
high amount (-4.5-fold). Five pro-apoptotic genes (BAX,
CIDEA, DFFA, FAS, and TNFRSF9) were up-regulated,
CIDEA (3.1-fold) and TNFRSF9 (7.3-fold) more than the
others, which were all close to the cut-off (Table 2). Of
the four anti-apoptotic genes, three (BAG1, BAG4, and
IGF1R) were slightly down-regulated and only BCL2A1
was up-regulated at a relatively high fold-change (5.3-
fold). Collectively, the up-regulation of the five pro-
apoptotic genes combined with down-regulation of three
anti-apoptotic genes would suggest that, on balance,
apoptosis would be favored.
Similarly, in A549 cells, ten pro-apoptotic genes
(APAF1, BAX, CASP3, CASP6, RIPK2, TNFRSF10B,
TNFRSF25, TNFRSF9, TNFSF10, and LTBR) and three
anti-apoptotic genes (BCL2A1, CD40LG, and XIAP) were
specifically altered by HSULF-1 over-expression. Of the
ten pro-apoptotic genes, nine (APAF1, BAX, CASP3,
CASP6, RIPK2, TNFRSF10B, TNFRSF25, TNFRSF9, and
TNFSF10) were up-regulated and only LTBR was down-
regulated. Of the three anti-apoptotic genes, two (BCL2A1
and CD40LG) were up-regulated and XIAP was down-
regulated. Collectively, the up-regulation of nine pro-
apoptotic genes combined with down-regulation of one
anti-apoptotic gene would suggest that apoptosis would
be favored. This further supported the interpretation
that over-expression of HSULF-1 reduced cell numbers
through apoptosis in transformed H292 and A549 cells
but not in hAT2 normal cells.
Over-expression of HSULF-1 inhibits ERK and Akt
signaling in lung cancer cell lines
It has been shown that HSULF-1 inhibits cell prolifera-
tion in several cancers and attenuates the activation of
ERK and Akt signaling [8,9,22,23], which is maintained
at a constitutively high level. The representative blot in
Figure 7 compares activation of two key signal transduc-
tion pathway elements, p-ERK and p-Akt, in H292 cells
untreated or transduced for lacZ or HSULF-1 over-
expression. Western blot analysis indicates that lacZ over-
expression slightly increased the levels of phosphorylated
ERK and p-Akt, compared with untreated controls.Over-expression of HSULF-1 reduced the levels of phos-
phorylated ERK and p-Akt, compared to both the un-
treated and lacZ over-expression controls (Figure 7A).
Densitometric analysis of p-ERK and p-Akt bands nor-
malized against total ERK and Akt, respectively, indi-
cated that over-expression of HSULF-1 significantly
inhibited the phosphorylation of ERK (1%) and Akt
(-38%) compared with untreated controls, and this in-
hibition was even more significant compared with lacZ
controls (Figure 7, B – C).
To determine whether the signaling inhibition induced
by HSULF-1 (i.e., loss of 6-O-sulfate groups) was revers-
ible, a low, biologically relevant dose (25 μg/ml) of hep-
arin, a model HSPG, was added to culture medium for 5
minutes. Heparin alone did not reduce the level of p-
ERK or p-Akt in control cells (non-transduced) nor in
lacZ over-expressing cells, but the inhibition of p-ERK
and p-Akt with HSULF-1 over-expression was reversed
to near control levels (Figure 7A). This was confirmed
by densitometric analysis (Figure 7, B – C). These results
indicate that the specific removal of 6-O-sulfate groups
from extracellular HSPGs by HSULF-1 reduced the high
level of constitutive ERK and Akt signaling in NSCLC
cells, and this inhibition could be reversed by a brief
pulse of sulfated heparin, which presumably counter-
balanced the loss of sulfates and thus restored 6-O-
sulfate-dependent signaling.
Discussion
HSULF-1 is an important inhibitor of tumor/cancer cell
growth [19] and is known to be down-regulated in vari-
ous cancers, such as ovarian, head and neck squamous
carcinoma, breast, gastric, kidney, and hepatocellular
cancers [8-10,18,22-24]. One mechanism of HSULF-1
down-regulation is epigenetic silencing of its promoter
region by hypermethylation [24]. It follows that down-
regulation of HSULF-1 would enhance tumor growth,
and it has been shown that over-expression of HSULF-1
in tumor cell lines inhibits specific, relevant signaling
pathways dependent on growth factors including FGF-2,
HB-EGF, HGF, and VEGF [9,10,13,18,23,25]. Lai, et al.,
demonstrated that reduced HSULF-1 expression in ovar-
ian cancers resulted in an increased sulfated environ-
ment, which acted to enhance HB-EGF signaling and
increase proliferation [18,20,23,26]. Another study found
that HSULF-1 was down-regulated in several head and
neck squamous carcinoma cell lines, and over-expression
of HSULF-1 attenuated the activation of ERK/MAPK/
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Figure 4 MTT assay for hAT2 (A – C) and H292 (D – F) cells over-expressing HSULF-1. Cells were infected with HSULF-1 adenovirus at
2, 5, 10, 20, 50, 100 MOIs with lacZ adenovirus as control at the same MOIs and cultured for 24, 48, or 72 hours. Values were normalized to
untreated cells and shown as mean± SD from 3 experiments. Significant differences compared with lacZ controls at p<0.05 are labeled by
* as determined by ANCOVA and followed by Student’s t-test.
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the FGF-2 signaling pathway is consistent with the fact
that 6-O-sulfate groups are requisite for the binding of
heparin to FGFR-1, which is necessary for forming a
ternary complex with FGF2, and their removal would
prevent this interaction [15]. These collective findings
support the notion that down-regulating HSULF-1 pro-
vides cancer cells an environment sufficient in highly sul-
fated HSPGs, which act to promote selective growth
factor signaling and attendant proliferation.
In this study, the goal was to determine the expression
of HSULF-1 in normal and transformed lung cells andits role in regulating cell signaling, survival, and apop-
tosis in vitro. Although investigated in several cell types
recently, the role of HSULF-1 in pulmonary cells remains
largely unknown. Results presented here demonstrate
that HSULF-1 expression is much lower in lung epithelial
cancer cells (A549, H292, H1975, H661, and H1703) than
normal cells (hAT2, HFL-1, 16Lu, HBE, and HLF)
(Figure 1). This is consistent with previous studies
showing that HSULF-1 down-regulation resulted in an
environment that promotes proliferation [10,18,23,26].
To study the role of HSULF-1 in tumor growth, we
chose to focus on its forced over-expression in H292
Figure 5 TUNEL assay of H292 cells over-expressing HSULF-1. Cells were infected with lacZ adenovirus alone (control, A) or HSULF-1
adenovirus at 2, 5, 10, 20, 50, and 100 MOIs (sequentially increasing, B – G). Seventy two hours post-infection, TUNEL assay was performed on
harvested cells. Photomicrographs were taken of random fields and a minimum of 3 fields from photomicrographs were selected and total cells
were counted in each field to achieve a minimum number of 150 total cells. (H) Apoptotic ratios as apoptotic cells/total cells are expressed as
Mean± SD from different fields. Significant differences between groups at p<0.05 as determined by Student’s t-test are indicated by the letters
above each bar, with different letters indicating significant differences between groups.
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http://respiratory-research.com/content/13/1/69cells (a lung epithelial cancer cell line) compared with
hAT2 cells. Consistent with previous findings, it was
found that at 72 hours after adenovirally-mediated over-
expression of HSULF-1, cell densities were visibly
reduced in H292 cells in a concentration-dependent
manner, but not in normal primary hAT2 cells (Figure 3).
This was confirmed by MTT assay, which demonstrated
that cell viability in H292 cells was significantly de-
creased by over-expression of HSULF-1 while hAT2 cells
were unaffected (Figure 4). These results confirmed pre-
vious studies in which restored/enhanced expression ofHSULF-1 reduced hepatocellular and breast cancer cell
proliferation both in vitro and in vivo [18,22]. To further
analyze the mechanisms of cell number reduction,
TUNEL assay was performed on H292 cells and results
showed that apoptosis was induced specifically by
HSULF-1 over-expression (Figure 5). This is in agree-
ment with previous studies that showed forced expres-
sion of HSULF-1 also increased the apoptosis induced
by apicidin (a HDAC inhibitor) in Huh7 and Hep3B
hepatocellular cell lines [9]. In addition, PCR array was
utilized to analyze apoptosis activation at the gene level.
Figure 6 Apoptosis pathway activation in hAT2 (A), H292 (B), and A549 (C) cells over-expressing HSULF-1. At 48 hours post-infection
with lacZ or HSULF-1 adenovirus at 10 MOI, mRNA was isolated and analyzed with an apoptosis PCR array. Genes significantly up- or
down- regulated more than 2-fold compared to lacZ adenovirus controls are labeled red or green, respectively.
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http://respiratory-research.com/content/13/1/69Results showed that in H292 and A549 cells, more genes
were activated, and more highly, by HSULF-1 over-
expression than in hAT2 cells. Among them, the
important cell death pathway effector BAX (induces
mitochondrial leakage) was activated in H292 and A549
cells but not in hAT2 cells. Notably, important caspase
family genes (CASP3, CASP6, and CASP8) and tumor
necrosis family (TNF) genes (TNFRSF10B, TNFRSF25,
or TNFSF10) were activated in H292 or A549 cells but
not in hAT2 cells (Tables 1, 2, and 3, Figure 6).Table 1 Genes that were up- or down-regulated in hAT2 cells
AT2 cells
Gene symbol Description
BCL2L11 BCL2-like 11 (apoptosis facilitator)
CASP7 Caspase 7
DAPK1 Death-associated protein kinase 1
TNFRSF9 TNF receptor superfamily member 9
BCL2A1 BCL2-related protein A1
IGF1R Insulin-like growth factor 1 receptor
hAT2 cells were infected with HSULF-1 adenovirus, total mRNA was isolated, and an
significantly up- or down- regulated more than 2-fold compared to lacZ adenovirusThese collective data suggest that normal cells may
control their expression of HSULF-1 in order to modu-
late the surrounding sulfated environment to optimize
responses to relevant growth factors. This is in agree-
ment with previous work demonstrating that the optimal
interactions of FGF-2 with their low affinity HSPG
receptors, or heparin surrogates, lie within a relatively
narrow range of concentration [27,28], and that these
interactions are sulfate dependent [29]. This paradigm is








Apoptosis PCR array was used to analyze gene expression. Genes that were
control are shown.
Table 2 Genes that were up- or down-regulated in H292 cells by HSULF-1
H292 cells
Gene symbol Description Function Fold change
BAX BCL2-associated X protein Pro-apoptosis 2.1
CASP6 Caspase 6 Pro-apoptosis −4.5
CASP8 Caspase 8 Pro-apoptosis −2.1
CIDEA Cell death-inducing DFFA-like effector a Pro-apoptosis 3.1
DFFA DNA fragmentation factor Pro-apoptosis 2.2
FAS TNF receptor superfamily member 6 Pro-apoptosis 2.3
TNFRSF9 TNF receptor superfamily member 9 Pro-apoptosis 7.3
TNFSF10 TNF superfamily member 10 Pro-apoptosis −2.8
GADD45A Growth arrest and DNA-damage-inducible, alpha Anti-proliferation 2
CD70 TNF superfamily member 7 Pro-proliferation 6.6
TNFSF8 TNF superfamily member 8 Pro-proliferation 5.3
MCL1 Myeloid cell leukemia sequence 1 Pro/anti-apoptosis 2.1
TP73 Tumor protein 73 Pro/anti-apoptosis 2.5
BAG1 Bcl-2-associated athanogene 1 Anti-apoptosis −2.3
BAG4 Bcl-2-associated athanogene 4 Anti-apoptosis −2
BCL2A1 BCL2-related protein A1 Anti-apoptosis 5.3
IGF1R Insulin-like growth factor 1 receptor Anti-apoptosis −2.2
H292 cells were infected with HSULF-1 adenovirus, total mRNA was isolated, and an Apoptosis PCR array was used to analyze gene expression. Genes that were
significantly up- or down- regulated more than 2-fold compared to lacZ adenovirus controls are shown.
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http://respiratory-research.com/content/13/1/69sulfated environment for maintenance and growth are
high, making them very sensitive to reductions in sulfa-
tion, as seen with increased HSULF-1.
The impact of alterations in ligand binding events at
the cell surface relating to FGF-2, VEGF, and HGF
would be expected to be reflected in subsequent signal-
ing pathways and account for the observed biological
outcomes. It has been suggested that HSULF-1’s hy-
drolysis of sulfate groups from HSPGs down-regulates
the receptor tyrosine kinase activity to attenuate cell
growth and survival through signaling pathways regu-
lated by FGF-2, VEGF, and HGF [19,30,31]. Based on
these findings, H292 cells were forced to over-express
HSULF-1 and levels of p-ERK and p-Akt, common
down-stream targets of signaling pathways triggered by
FGF-2, VEGF, and HGF, were analyzed. Results showed
that p-ERK and p-Akt were inhibited by HSULF-1, and
this inhibition was significantly reversed by restoring sul-
fated proteoglycans by addition of heparin (Figure 7).
This is in agreement with previous studies showing that
the loss of response of cells to FGF when lacking en-
dogenous heparan sulfate can be restored by the ad-
dition of exogenous heparin [12]. Notably, both basal
expression of p-ERK and p-Akt were high in the H292
cells compared with normal hAT2 cells (data not shown),
which is typical of cancer cells [32,33] and may account
for the heightened sensitivity to HSULF-1-induced re-
duction in signaling. A plausible mechanism for the
apoptosis caused by HSULF-1 over-expression is that thesignificant reduction in p-ERK and p-Akt is sufficient to
block proliferation and promote apoptosis and cell death
in H292 cells, as the anti-tumor drug periplocin does in
another NSCLC, A549, through its blockage of ERK and
Akt pathways [34].
Interestingly, in contrast to inhibiting ERK and Akt
signaling, HSULF-1 has been found to stimulate Wnt
signaling and thus increase proliferation in pancreatic
cancers [35,36], which reveals that the role of HSULF-1
is somewhat complicated. Recent studies found that
HSULF-1 is up-regulated in acute myeloid leukemia, pan-
creatic adenocarcinomas, T prolymphocytic leukemia,
and in renal carcinoma, compared to corresponding nor-
mal tissues [37]. Furthermore, it has been shown that
HSULF-1 is expressed at higher levels in lung cancer pa-
tient samples compared with normal tissues, and high
HSULF-1 expression could be associated with a poor
prognosis in lung adenocarcinoma [37].
Several reasons to account for these apparent contra-
dictions have been proposed. First, as shown in our
experiments, the expression of HSULF-1 was compared
in five lung cancer cell lines and five normal lung cells
which were both randomly selected. After log transform-
ation of the RT-PCR data, the results showed that the
expression of HSULF-1 was significantly higher in nor-
mal cells than in cancer cells, with a p-value of 0.0004.
This indicates that the wide variation in HSULF-1 ex-
pression and its effects may be explained in part by the
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Figure 7 ERK and Akt activation was inhibited by HSULF-1 but restored by heparin in H292 cells. Cells were infected with lacZ or
HSULF-1 adenovirus at 10 MOI, cultured for 48 hours, and exposed to 25 μg/ml heparin for 5 minutes. Top, Western blot analysis (A). Bottom,
Densitometric analysis of p-ERK (B) and p-AKT (C). Integrated optical density values were analyzed using Image J, normalized to total ERK and Akt,
and expressed as percentage of Control with means ± SD from 3 experiments. * Significant differences at p<0.05 compared to control cells, as
determined by t-test.
Table 3 Genes that were up- or down-regulated in A549 cells by HSULF-1
A549 cells
Gene symbol Description Function Fold change
APAF1 Apoptotic peptidase activation factor 1 Pro-apoptosis 2.1
BAX BCL2-associated X protein Pro-apoptosis 2.1
CASP3 Caspase 3 Pro-apoptosis 2.2
CASP6 Caspase 6 Pro-apoptosis 2.1
RIPK2 Receptor-interacting serine/threonine-protein kinase2 Pro-apoptosis 5.8
TNFRSF10B TNF receptor superfamily member 10B Pro-apoptosis 2.5
TNFRSF25 TNF receptor superfamily member 25 Pro-apoptosis 2.4
TNFRSF9 TNF receptor superfamily member 9 Pro-apoptosis 2.3
TNFSF10 TNF superfamily member 10 Pro-apoptosis 2.9
LTBR lymphotoxin beta receptor Pro-apoptosis −2.7
BCL2A1 BCL2-related protein A1 Anti-apoptosis 2.4
CD40LG CD40 ligand Anti-apoptosis 2.0
XIAP X-linked inhibitor of apoptosis protein Anti-apoptosis −2.2
A549 cells were infected with HSULF-1 adenovirus, total mRNA was isolated, and an Apoptosis PCR array was used to analyze gene expression. Genes that were
significantly up- or down- regulated more than 2-fold compared to lacZ adenovirus controls are shown.
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http://respiratory-research.com/content/13/1/69and genetic variances in patient tissues. Second, in the
study by Bret, et al., paired samples were obtained by
surgical resection from lung squamous carcinoma and
non-malignant neighboring tissues, which should con-
tain different types of cells. Not only the cancer cells but
also the cancer stromal cells may secrete HSULF-1,
which may play different roles when produced by differ-
ent cell types [37]. Also, the contributions of surround-
ing non-cancerous cells and a patient’s immune system
to the local levels of HSULF-1 in an effort to combat a
highly-aggressive cancer cannot be discounted. Thus, the
up-regulation of HSULF-1 mentioned in lung squamous
carcinoma may be explained partly by the increased ex-
pression in surrounding cells. Third, recently-described
splice variants of Quail SULF-1 apparently have different
functions, as the longer isoform A functions to enhance
Wnt signaling while the shorter isoform B inhibits Wnt
signaling but promotes angiogenesis [38]. The presence
of SULF-1 alternate splicing forms has not yet been
confirmed in humans, but it would be logical that a
functional isoform could counterbalance or negate the
function of the longer HSULF-1 or otherwise contribute
to metaplasia in those human cancers over-expressing
the isoform. Interestingly, and most recently, HSULF-1
gene polymorphisms were found to correlate with the
age of onset, severity, and progression of ovarian cancer
in a small study of human patients [39], adding yet an-
other layer of complexity to be explored.
Conclusions
Collectively, the present study reveals that HSULF-1 is
expressed at lower levels in several lung cancer cell lines
than in normal cells and its over-expression in H292
cells reduces cell viability and induces apoptosis by inhi-
biting ERK and Akt signaling. HSULF-1 plays important
but complicated roles in cancer progression and inhib-
ition depending on organ/tissue sites, cell types, environ-
ment, and those signaling pathways it affects. It should
be viewed as an important target of cancer treatment.
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